BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.
BRITANNIA LIFE SCIENCES (L020) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, BRITANNIA LIFE SCIENCES (L020) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BRITANNIA LIFE SCIENCES - Net Assets Trend (None–None)
This chart illustrates how BRITANNIA LIFE SCIENCES's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BRITANNIA LIFE SCIENCES (None–None)
The table below shows the annual net assets of BRITANNIA LIFE SCIENCES from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BRITANNIA LIFE SCIENCES's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BRITANNIA LIFE SCIENCES Competitors by Market Cap
The table below lists competitors of BRITANNIA LIFE SCIENCES ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Gulf Resources, Inc. (NV) Common Stock
NASDAQ:GURE
|
$4.76 Million |
|
enVVeno Medical Corp
NASDAQ:NVNO
|
$4.76 Million |
|
Orpheus Uranium Ltd
AU:ORP
|
$4.76 Million |
|
Blue Star Gold Corp
OTCQB:BAUFF
|
$4.76 Million |
|
TZ Ltd
AU:TZL
|
$4.76 Million |
|
Ozaurum Resources Ltd
AU:OZM
|
$4.76 Million |
|
Immuron Ltd
AU:IMC
|
$4.76 Million |
|
Photozou Holdings Inc
PINK:PTZH
|
$4.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BRITANNIA LIFE SCIENCES's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BRITANNIA LIFE SCIENCES's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BRITANNIA LIFE SCIENCES utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BRITANNIA LIFE SCIENCES's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BRITANNIA LIFE SCIENCES (L020) | €- | N/A | N/A | $4.76 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |